Diabetic nephropathy: newer therapeutic perspectives
Diabetic nephropathy (DN is a dreaded consequence of diabetes mellitus, accounting for about 40% of end-stage renal disease (ESRD). It is responsible for significant morbidity and mortality, both directly by causing ESRD and indirectly by increasing cardiovascular risk. Extensive research in this fi...
Saved in:
Main Authors: | Krishna C. Keri (Author), Naga S. Samji (Author), Samuel Blumenthal (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can newer anti-diabetic therapies delay the development of diabetic nephropathy?
by: Sohail Aziz, et al.
Published: (2021) -
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
by: Matthew D. Krasowski
Published: (2010) -
Newer goals!!!
by: Balaji Manohar
Published: (2012) -
Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
by: Qichao Hu, et al.
Published: (2021) -
The role of innate immunity in diabetic nephropathy and their therapeutic consequences
by: Min Yang, et al.
Published: (2024)